The problem of relieving the pain and discomfort of breast engorgement in the puerperium, espiecially in the non-nursing mother, has been an unsatisfactory one. The unhappiness of the patient and the not infrequent complications of cellulitis and abscess formation have led to the application of many and varied therapeutic measures. Heretofore the measures employed, such as tight breastbinding, restriction of fluids, saline cathartics, ice-packs, hot-packs, massage, and injections of camphor in oil, have in themselves been as discomforting as the breast engorgement. At present a physiological approach toward the solution of this difficulty gives great promise of success in a very high percentage of cases. This has become possible through a better understanding of the physiology of lactation and of hormonal therapy.
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Though painful engorgement of the breasts is said to be caused by lymphatic and venous stasis' and not by distention of the ducts with milk, we know from clinical observation that with evacuation and drainage of the milk the pain and stasis will quickly subside. There appears to be a cause and effect relationship between these two phenomena. If we could, therefore, prevent over-distention of the ducts we might possibly prevent congestion, stasis, and pain.
In the physiology of lactation two factors play a related role. The first, a hormonal one, which initiates lactation, and the second, a neurogenic one, which maintains lactation. The hormonal factor involves stimulation of the breasts by the ovarian hormones (estrogen and progestin) and by the lactogenic principles of the anterior lobe of the hypophysis. The neurogenic factor is stimulated by suckling or by pumping of the breasts. This latter factor affords a mechanical stimulus, the lack of which permits a cessation of the milk supply. The release of lactogen only occurs when the inhibiting effect of estrogen is withdrawn. This withdrawal occurs only after delivery.
If our conception of the physiology of lactation is correct it could be postulated that by preventing or modifying the hormonal changes which follow parturition, treatment should be more successful. The use of Stilbestrol appears to do this. Stilbestrol* is a synthetic hormone-like preparation whose action is the same as that of the natural estrogens. It is stated to be about 20 times more active than is estrone and 5 or 6 times more active than is estradiol benzoate when taken by mouth.4 Its action is the same as that of the natural estrogens. It can induce a proliferation of the endometrium, abolish deficiency manifestations of the climacteric, stimulate the growth of a hypoplastic uterus, abolish the pain of dysmenorrhea, and prevent or inhibit lactation. 4 Stilbestrol may be administered orally or intramuscularly. No matter which route is used certain toxic symptoms, such as nausea, vomiting, pyrosis, and vertigo, may occur. The severity of these toxic symptoms is independent of the dosage employed or of route of administration, e.g., severe reactions occurring with small doses or nausea and vomiting appearing with intramuscular doses. There occurred both a primary (3rd-5th day) and a secondary (7th-10th day) engorgement. These were soft, and absolutely painless in 75 per cent of the cases.
There occurred in many of the cases a leakage of a thin, watery secretion during the secondary engorgement.
The severe pain was evidenced during the secondary engorgement.
No toxic reactions were noted in any of the cases. Neither gravidity nor previous nursing had any apparent influence upon the results.
The temperature rise often seen with breast engorgement was absent in all instances.
Discussion
The results of this small series parallel those of other investigators. Abarbanel In a control series (no hormones used), Abarbanel and Goodfriend' encountered severe painful engorgement in 47.7 per cent of cases, mild pain in 44.6 per cent, and no pain in 7.7 per cent. Though no control series was run in conjunction with the cases reported in this paper, subsequent study revealed an incidence in approximately the same proportions.
The onset of lactation can also be retarded or even suppressed. In retarding the onset, Stilbestrol inhibits the release of lactogenby maintaining the estrogenic level following parturition. In the suppression of lactation, the important factor is not Stilbestrol, but is the absence of nursing (the nervous stimulus).
Despite the use of the drug, lactation need not be suppressed. This was shown by Case 12 when the mother, after having received 20 mg. of Stilbestrol, decided to nurse the infant. The ensuing milk supply was adequate for the infant. Stewart and Pratt' found a variable individual response in milk production after the use of Stilbestrol, showing that "inhibition of breast engorgement is not synonymous with inhibition of lactation."
